Brief: Nabriva Therapeutics Posts Qtrly Loss Per Share $1.11
11/03/2021 23:04
March 11 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* QUARTERLY REVENUE $2.5 MILLION VERSUS $300,000
* QTRLY LOSS PER SHARE $1.11
Source: [https://bit.ly/3qE6C7u]
Further company coverage: NBRV.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update